Efficacy of dextromethorphan for the treatment of depression: a systematic review of preclinical and clinical trials
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy of dextromethorphan for the treatment of depression: a systematic review of preclinical and clinical trials
Authors
Keywords
-
Journal
EXPERT OPINION ON EMERGING DRUGS
Volume -, Issue -, Pages 1-12
Publisher
Informa UK Limited
Online
2021-03-08
DOI
10.1080/14728214.2021.1898588
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Combination of dextromethorphan and memantine in treating bipolar spectrum disorder: a 12-week double-blind randomized clinical trial
- (2020) Sheng-Yu Lee et al. International Journal of Bipolar Disorders
- The Effectiveness of Repeated Intravenous Ketamine on Depressive Symptoms, Suicidal Ideation and Functional Disability in Adults with Major Depressive Disorder and Bipolar Disorder: Results from the Canadian Rapid Treatment Center of Excellence
- (2020) Roger S McIntyre et al. JOURNAL OF AFFECTIVE DISORDERS
- Dextromethorphan Abuse Among Opioid-Dependent Patients
- (2020) Laura G. Windhab et al. CLINICAL NEUROPHARMACOLOGY
- Assessment of the rapid and sustained antidepressant-like effects of dextromethorphan in mice
- (2020) Jesus S. Saavedra et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- A Randomized Controlled Trial of Intranasal Neuropeptide Y in Patients With Major Depressive Disorder
- (2020) Aleksander A Mathé et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
- (2020) Theo Vos et al. LANCET
- Burden of Treatment Resistant Depression (TRD) in patients with major depressive disorder in Ontario using Institute for Clinical Evaluative Sciences (ICES) databases: Economic burden and healthcare resource utilization
- (2020) Roger S. McIntyre et al. JOURNAL OF AFFECTIVE DISORDERS
- Bipolar disorders
- (2020) Roger S McIntyre et al. LANCET
- Factor analyses differentiate clinical phenotypes of idiopathic and interferon-alpha-induced depression
- (2019) Richard Whale et al. BRAIN BEHAVIOR AND IMMUNITY
- Interferon-alpha-induced depression: Comparisons between early- and late-onset subgroups and with patients with major depressive disorder
- (2019) Kuan-Pin Su et al. BRAIN BEHAVIOR AND IMMUNITY
- Rapid‐acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective
- (2019) Kenji Hashimoto PSYCHIATRY AND CLINICAL NEUROSCIENCES
- Dextromethorphan/Bupropion: A Novel Oral NMDA (N-methyl-d-aspartate) Receptor Antagonist with Multimodal Activity
- (2019) Stephen M. Stahl CNS SPECTRUMS
- P.601 AXS-05 (dextromethorphan/bupropion), a novel, oral, investigational agent for major depressive disorder: Results of a randomized, double-blind, active-controlled, multi-center trial (ASCEND)
- (2019) C. O'gorman et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Antidepressant Efficacy and Tolerability of Ketamine and Esketamine: A Critical Review
- (2018) P. Molero et al. CNS DRUGS
- Neurogenesis in the adult hippocampus: history, regulation, and prospective roles
- (2018) Jawad Fares et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- Treatment effectiveness and tolerability outcomes that are most important to individuals with bipolar and unipolar depression
- (2018) Joshua D. Rosenblat et al. JOURNAL OF AFFECTIVE DISORDERS
- Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
- (2018) Spencer L James et al. LANCET
- Dextromethorphan/quinidine pharmacotherapy in patients with treatment resistant depression: A proof of concept clinical trial
- (2017) James W. Murrough et al. JOURNAL OF AFFECTIVE DISORDERS
- The COMT Val158Met Polymorphism Is Associated With Response to Add-on Dextromethorphan Treatment in Bipolar Disorder
- (2017) Sheng-Yu Lee et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Deuterated (d6)-dextromethorphan elicits antidepressant-like effects in mice
- (2017) Linda Nguyen et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- New targets for rapid antidepressant action
- (2017) Rodrigo Machado-Vieira et al. PROGRESS IN NEUROBIOLOGY
- Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder
- (2016) Raymond W. Lam et al. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
- Neurobiology of Depression and Mechanism of Action of Depression Treatments
- (2016) Pierre Blier JOURNAL OF CLINICAL PSYCHIATRY
- Behavioral and biochemical effects of ketamine and dextromethorphan relative to its antidepressant-like effects in Swiss Webster mice
- (2016) Linda Nguyen et al. NEUROREPORT
- The involvement of NMDA receptor/NO/cGMP pathway in the antidepressant like effects of baclofen in mouse force swimming test
- (2016) Muhammad Imran Khan et al. NEUROSCIENCE LETTERS
- Dextromethorphan: An update on its utility for neurological and neuropsychiatric disorders
- (2016) Linda Nguyen et al. PHARMACOLOGY & THERAPEUTICS
- Pharmacology of dextromethorphan: Relevance to dextromethorphan/quinidine (Nuedexta®) clinical use
- (2016) Charles P. Taylor et al. PHARMACOLOGY & THERAPEUTICS
- Role of calcium, glutamate and NMDA in major depression and therapeutic application
- (2016) Lorenz Deutschenbaur et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Involvement of AMPA receptors in the antidepressant-like effects of dextromethorphan in mice
- (2015) Linda Nguyen et al. BEHAVIOURAL BRAIN RESEARCH
- Maintaining the Initial Clinical Response After Ketamine in Bipolar and Unipolar Depression: An Important Next-Step Challenge
- (2015) Dan V. Iosifescu JOURNAL OF CLINICAL PSYCHIATRY
- Repeated, high-dose dextromethorphan treatment decreases neurogenesis and results in depression-like behavior in rats
- (2015) Kai Ting Po et al. EXPERIMENTAL BRAIN RESEARCH
- Therapeutic effects of add-on low-dose dextromethorphan plus valproic acid in bipolar disorder
- (2014) Shiou-Lan Chen et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- The utility of the combination of dextromethorphan and quinidine in the treatment of bipolar II and bipolar NOS
- (2014) Tammas Frederick Kelly et al. JOURNAL OF AFFECTIVE DISORDERS
- Involvement of Sigma-1 Receptors in the Antidepressant-like Effects of Dextromethorphan
- (2014) Linda Nguyen et al. PLoS One
- COGNITIVE DEFICITS AND FUNCTIONAL OUTCOMES IN MAJOR DEPRESSIVE DISORDER: DETERMINANTS, SUBSTRATES, AND TREATMENT INTERVENTIONS
- (2013) Roger S. McIntyre et al. DEPRESSION AND ANXIETY
- Ketamine-induced antidepressant effects are associated with AMPA receptors-mediated upregulation of mTOR and BDNF in rat hippocampus and prefrontal cortex
- (2013) W. Zhou et al. EUROPEAN PSYCHIATRY
- Antidepressant effects of AMPA and ketamine combination: role of hippocampal BDNF, synapsin, and mTOR
- (2013) Luli Akinfiresoye et al. PSYCHOPHARMACOLOGY
- Agomelatine, a novel intriguing antidepressant option enhancing neuroplasticity: A critical review
- (2013) Maurizio Pompili et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- The DRD2/ANKK1 gene is associated with response to add-on dextromethorphan treatment in bipolar disorder
- (2012) Sheng-Yu Lee et al. JOURNAL OF AFFECTIVE DISORDERS
- An extension of hypotheses regarding rapid-acting, treatment-refractory, and conventional antidepressant activity of dextromethorphan and dextrorphan
- (2012) Edward C. Lauterbach MEDICAL HYPOTHESES
- Chronic antidepressant treatments induce a time-dependent up-regulation of AMPA receptor subunit protein levels
- (2011) Alessandro Barbon et al. NEUROCHEMISTRY INTERNATIONAL
- Sigma receptors: Potential targets for a new class of antidepressant drug
- (2010) James A. Fishback et al. PHARMACOLOGY & THERAPEUTICS
- Behavioral animal models of depression
- (2010) Hua-Cheng Yan et al. Neuroscience Bulletin
- Sex Differences in Animal Models of Depression and Antidepressant Response
- (2009) Christina Dalla et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Therapy-resistant depression
- (2009) Tom Bschor Expert Review of Neurotherapeutics
- Duloxetine in acute major depression: review of comparisons to placebo and standard antidepressants using dissimilar methods
- (2009) Paolo Girardi et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Sigma-1 receptor knockout mice display a depressive-like phenotype
- (2008) Valentina Sabino et al. BEHAVIOURAL BRAIN RESEARCH
- Further evidence for an antidepressant potential of the selective σ1 agonist SA 4503: electrophysiological, morphological and behavioural studies
- (2008) Guillaume Lucas et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now